Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 diabetes—mostly due to a lack of early screening, poor blood sugar control, and delayed ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

A diabetic eye screening appointment usually takes about 30 minutes: We’ll ask you to read some letters on a chart. We’ll put drops in your eyes. These may sting for a few seconds and may make your ...

Breye Therapeutics has announced that danegaptide, a potential oral treatment for nonproliferative diabetic retinopathy, has ...

According to Varma, African Americans have a high rate of visual impairment and are especially likely to develop open-angle ...

An AI model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient.

The trial subjects were adults with either type 1 or type 2 diabetes, exhibiting central involvement in diabetic macular ...

A target A1C of 7% is a common goal for adults with diabetes, helping reduce long-term complications and improve blood sugar ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Visakhapatnam: A three-day international conference on “Innovations in Healthcare: Smart and Advanced Applications (IHCSAA)” ...